ORIGINAL RESEARCH article
Front. Public Health
Sec. Public Health Policy
This article is part of the Research TopicAddressing Health Disparities through Global Disease Burden Analysis: From Evidence to Equitable PolicyView all 6 articles
Cervical Cancer Burden Among Females Under 40 Years in China, Japan, and South Korea, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021
Provisionally accepted
- Department of Gynaecology and Obstetrics, The Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Cervical cancer remains a major global public health concern; however, its burden among younger women in East Asia has not been systematically characterized across spatial, temporal, and age dimensions. Methods: This study analyzed the incidence, prevalence, mortality, and DALYs of cervical cancer among females aged < 40 years in China, Japan, and South Korea from 1990 to 2021 using GBD 2021 data. The results highlight distinct geographic and temporal patterns with urgent implications for public health policies. Strengthening HPV vaccination, expanding screening, and targeted campaigns are critical to reducing the burden and aligning with the WHO elimination goals. Results: Between 1990 and 2021, the burden of cervical cancer among females aged < 40 years in China, Japan, and South Korea showed distinct geographic and temporal patterns. In 2021, Japan maintained the highest incidence, prevalence, and DALYs, whereas China recorded the highest mortality. Temporal trends indicated a rising incidence in Japan and China but a decline in South Korea, while mortality and DALY rates decreased substantially in China and South Korea and remained low in Japan. Across all countries, the burden was predominantly concentrated in women aged 30–39 years, with a stable overall age composition, but a slight increase in the proportion of the 35–39-year group over time. Conclusions: Despite modest reductions in age-standardized burden, cervical cancer remains a significant issue for women under 40 years of age in East Asia, compounded by suboptimal HPV vaccine uptake and COVID-era disruptions. Therefore, strengthening vaccination, expanding screening, and launching public health campaigns are urgent priorities.
Keywords: cervical cancer, Global Burden of Disease (GBD), East Asia, Epidemiology, Public Health
Received: 29 Aug 2025; Accepted: 31 Oct 2025.
Copyright: © 2025 Xiao, Deng, Ren and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Chan Zhang, 18153752901@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.